30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

1Q14 Revenue: Zimmer

$1,161.5MM, +3% (Americas $638MM, +1%; Europe $327MM, +4%; Asia Pacific $196MM, +8%)

Reconstructive $872MM, +4% (Americas $473MM, +2%; Europe $257MM, +4%; Asia Pacific $142MM, +9%)

  • Hips $332MM, +2% (Americas $150MM, flat; Europe $116MM, +1%; Asia Pacific $66MM, +7%)
  • Knees $488MM, +5% (Americas $284MM, +3%; Europe $131MM, +5%; Asia Pacific $73MM, +10%)
  • Extremities $52MM, +9%

Dental $61MM, +2%

Trauma $79MM, -1%

Spine $48MM, +1%

Surgical/Other $101MM, +3%

 

  • In early 2Q, announced intention to acquire Biomet (revenue call primarily addressed transaction)
  • Price pressure update -2% overall (Hips -2%, knees -3%)